CTOs on the Move

Beiersdorf, Inc.

www.bdfusa.com

 
Beiersdorf, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Wilton, CT. To find more information about Beiersdorf, Inc., please visit www.bdfusa.com
  • Number of Employees: 0-25
  • Annual Revenue: $500M-1 Billion
  • www.bdfusa.com
  • 187 Danbury Rd
    Wilton, CT USA 06897-4003
  • Phone: 203.563.5800

Executives

Name Title Contact Details

Similar Companies

Polyfoam Corp

Polyfoam Corp is a Northbridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stafford Suites

Stafford Suites is a Sumner, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BL Software Systems/BL Healthcare

BL Software Systems/BL Healthcare is a Foxborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SunLink Health Systems, Inc.

SunLink Health Systems, Inc. currently operates seven community hospitals and related nursing home and home care businesses in the Southeast and Midwest, and its specialty pharmacy business, SunLink Scripts Rx, in Louisiana and Georgia. Each SunLink hospital is the only hospital in its community. SunLink's operating strategy is to link patients' needs with dedicated physicians and health professionals to deliver quality, efficient medical care and healthcare products and services in each area it serves. For additional information on SunLink Health Systems, Inc.

Diagnocure

DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.